Thursday, November 26, 2020
In this episode, host David H. Henry, MD, highlights some recent articles from Blood, the Journal of Clinical Oncology, and the New England Journal of Medicine.
Blood
- How I Treat series on hematologic complications in pregnancy. https://bit.ly/3fr5nV8
- Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia. https://bit.ly/3nQvhF6
Journal of Clinical Oncology
- Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. https://bit.ly/3maTOE4
- Related Blood & Cancer episode:
Cancer and hepatitis B virus: ASCO's recommendations for HBV screening, monitoring for reactivation, and how to treat patients. https://bit.ly/3m0jjrF
- Related Blood & Cancer episode:
- Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy. https://bit.ly/372FFCB
- Chemotherapy and COVID-19 Outcomes in Patients With Cancer. https://bit.ly/35WRLOi
- Related Blood & Cancer episodes:
Studying cancer patients with COVID-19: NCCAPS and CCC19. https://bit.ly/3pYl2Au
TERAVOLT registry sheds light on patients with thoracic cancers and COVID-19. https://bit.ly/2URdwJh
- Related Blood & Cancer episodes:
- Diffuse Large B-Cell Lymphoma’s New Genomics: The Bridge and the Chasm. https://bit.ly/36XdGnY
New England Journal of Medicine
- Osimertinib in Resected EGFR-Mutated Non–Small Cell Lung Cancer. https://bit.ly/2J5q7FQ
- Humoral Immune Response to SARS-CoV-2 in Iceland. https://bit.ly/2USw7ET
- Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. https://bit.ly/39aM0ia
- Remdesivir for the Treatment of COVID-19 – Final Report. https://bit.ly/375dYJk
- Remdesivir for 5 or 10 Days in Patients with Severe COVID-19. https://bit.ly/2IZJ7Wq
Disclosures:
Dr. Henry has no relevant disclosures.
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgehemonc
David Henry on Twitter: @davidhenrymd
How to Listen